Kerry Group is negotiating a “bet the farm” €22.5 billion merger with DuPont’s nutrition business
DuPont wants to spin out its nutrition and biosciences business. Kerry is said to be in the lead to buy it. The reported price tag is €22.5 billion, which is more than Kerry’s entire enterprise value. Could the deal work?
30th Oct, 2019 - 7 min read
What does Bank of China want from Goodbody? And can it be trusted to follow through?
Davy and the Bank of China are the two leading contenders to buy Goodbody stockbrokers. Fexco, the 51% owner of Goodbody, will have the final say. For Goodbody staff, who own the remaining 49%, a lot is at stake.
24th Oct, 2019 - 7 min read
WeWork grew too fast. Now it is cutting back. Will its Irish property deals be honoured?
If WeWork survives, a change of direction is coming. What will happen to its Irish tenants and landlords? Using interactive mapping, we look at WeWork’s operations in Dublin – the offices, the work in progress and the SPV structure underpinning its model.
22nd Oct, 2019 - 5 min read
Discarded in a junk stock: the Irish skin-clone science that built an €18 million business
Integumen was on life support when Gerry Brandon spotted the potential of its skin cloning technology. He acquired it, and a year later the stock is up 1,252 per cent. What’s next?
21st Oct, 2019 - 10 min read
Inside Paddy Power’s mega-merger: in the gambling business, better to be big
To justify the current share price of Paddy Power, it would help for the merger with Stars to go through. More importantly, Flutter needs billions of dollars to flow, from punters all over America, into their slick new FanDuel Sportsbook apps.
3rd Oct, 2019 - 11 min read
Corporate Currency: Bank of Ireland needs to find a business model. But just what is it?
It’s still undoing mistakes and retreating from bad markets. And its profitability is still being dragged down by tough capital requirements. But in Ireland, it has a chance of success.